Pfizer leans into gene therapy manufacturing with 'build-buy-partner' strategy

On Wednesday, Pfizer and gene therapy maker Vivet Therapeutics partnered on a manufacturing deal for a Wilson's disease candidate that will be produced at Pfizer's Chapel Hill, North Carolina plant, the companies said.